{
    "Trade/Device Name(s)": [
        "Wondfo CR3 Keyless Split Sample Cup",
        "Multi-Drug Urine Test Cup"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K151478",
    "Predicate Device Reference 510(k) Number(s)": [
        "K141532",
        "K140089",
        "K142044",
        "K142609",
        "K143535",
        "K150179",
        "K150602"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "LFG",
        "LCM",
        "DKZ",
        "DIS",
        "JXM",
        "LDJ",
        "DIO",
        "LAF",
        "DJR"
    ],
    "Summary Letter Date": "May 26, 2015",
    "Summary Letter Received Date": "June 2, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3170",
        "21 CFR 862.3150",
        "21 CFR 862.3620",
        "21 CFR 862.3910"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Amphetamine Test System",
        "Cannabinoids Test System",
        "Cocaine and Cocaine Metabolites Test System",
        "Methamphetamine Test System",
        "Benzodiazepine Test System",
        "Barbiturate Test System",
        "Methadone Test System",
        "Tricyclicantidepressant drug Test System"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "tdm"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Secobarbital",
        "Oxazepam",
        "Cocaine",
        "Cannabinoids",
        "Methamphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Phencyclidine",
        "Oxycodone",
        "Buprenorphine",
        "Methadone",
        "Notriptyline"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        "Split Sample Cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunochemistry",
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cup",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo CR3 Keyless Split Sample Cup multi-drug urine screening device using competitive lateral flow immunoassay technology",
    "Indications for Use Summary": "Qualitative, simultaneous detection of multiple drugs of abuse (Amphetamine, Secobarbital, Oxazepam, Cocaine, Cannabinoids, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Phencyclidine, Oxycodone, Buprenorphine, Methadone, Notriptyline) in human urine at specified cutoff concentrations as a preliminary screen",
    "fda_folder": "Toxicology"
}